| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6015175 | Epilepsy Research | 2016 | 27 Pages |
Abstract
Among adult and pediatric patients in the UK, CLB is more often prescribed for epilepsy than CZP. The median CLB dosage used by both adults and children remained stable over the 16-year study period, while the median CZP dosage increased in both adults and children.
Keywords
AEDBNFBZDBritish National FormularyCZPISACMHRANDDCPRDLGSCLBbenzodiazepineNICEMedicines and Healthcare products Regulatory Agencyantiepileptic drugsantiepileptic drugLennox–Gastaut syndromeNational Institute for Health and Care ExcellenceCohort studiesOutcome researchAll epilepsy/seizuresClobazamClonazepam
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Martin J. Brodie, Steve Chung, Alan Wade, Céline Quelen, Alice Guiraud-Diawara, Clément François, Patrice Verpillat, Vivienne Shen, Jouko Isojarvi,